Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts
Title
Grant Type
Focus Area
Country
Application Due Date
BCMA-Directed Bispecific Antibody Treatment in Multiple Myeloma
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Oncology Japan
Research on MBL producing Enterobacterales and/or Stenotrophomonas maltophilia
Release Date:
Review Process: Pfizer Internal
Research Hospital Austria, Brazil, China, France, Germany, Greece, India, Italy, Mexico, Saudi Arabia, Spain, Taiwan, Turkey, United Kingdom
Increase Awareness & Understanding of Emerging Hemophilia Treatment Options (Global excluding United States)
Release Date:
Review Process: Pfizer Internal
Education Rare Disease All
Optimal management of patients with prostate cancer receiving androgen deprivation therapy (ADT)
Release Date:
Partner: Sumitomo Pharma
Review Process: Pfizer Internal
Education Oncology USA
Title
Grant Type
Focus Area
Country
Application Due Date
Educational Activities to Improve Vaccination Rate beyond Clinical Departments
Release Date:
Review Process: Pfizer Internal
Education Vaccines Japan
Promotion of the Appropriate Diagnosis and Treatment of Pediatric Neurogenic Bladder
Release Date:
Review Process: Pfizer Internal
Education Internal Medicine Japan
Developing Clinical Research and Publication Skills(Asia, AfME, Latin America and China)
Release Date:
Partner: British Medical Journal (BMJ)
Review Process: Expert Review Panel
Education Internal Medicine All
A Phased Approach to Understanding and Addressing Healthcare Disparities for People of Color
Release Date:
Partner: Conquer Cancer, The ASCO Foundation
Review Process: Expert Review Panel
Research Oncology USA
PCF-Pfizer-Myovant Relugolix Challenge Awards
Release Date:
Partner: The Prostate Cancer Foundation and Myovant Sciences GmbH
Review Process: Expert Review Panel
Research Oncology USA
BRAF-mutation Biomarker Testing in Colorectal Cancer and Melanoma
Release Date:
Review Process: Pfizer Internal
Translation: French (link)
Quality Improvement Oncology Canada
Pfizer Innovation Challenge: Patient Preference Database Blueprint
Release Date:
Review Process: Expert Review Panel
Research Support for the Professions All
Management of Uterine Fibroids and Endometriosis
Release Date:
Partner: Myovant Sciences
Review Process: Pfizer Internal
Education Internal Medicine USA
COVID-19 Impact and SARS-CoV-2 Viral Lifecycle
Release Date:
Review Process: Pfizer Internal
Education Hospital USA
Addressing Knowledge Gaps on Biosimilar Use in Inflammatory Conditions
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
Dermatology Research Fellowship in Skin of Color
Release Date:
Partner: Skin of Color Society
Review Process: Expert Review Panel
Fellowship Inflammation & Immunology USA
NSCLC Therapy Management for Optimal Outcomes(Asia, Africa, Middle East, Latin America)
Release Date:
Review Process: Pfizer Internal
Quality Improvement Oncology All